December 4, 2018: Clinical Site Management: The Key to Successful Trials

Date
8am - 10am
Location
Biocom: McGraw Boardroom- 10996 Torreyana Rd. Suite 200, San Diego, CA 92121

Clinical Site Management: The Key to Successful Trials

Almost nine in ten clinical trials fail. While some failure is inevitable based on the development of the science, this figure is astoundingly, unacceptably high. Especially after spending over a billion dollars on average per trial and over a decade in development.

Why do so many clinical trials fail? There are many of the usual suspects ¬– excuses such as lack of efficacy, safety concerns, strategic reasons and economics, or some combination of these. Bull!

The real reasons: poor study design, increasingly complex protocols, poor trial management, lack of site involvement in study design, and weak teams. Awkward reasons managers don’t like to discuss, because they have to do with the quality of the clinical trial management and site selection. These are things you can do something about.

On December 4, the Biocom CRO group will present a panel of highly experienced and successful clinical trial managers, sponsors, monitors and site managers who will discuss their experiences, best practices and the lessons they have learned on the way to clinical trial success (and failure).

Lessons you can now learn for free…

Speakers: John Neal, Moderator, Founder and Chairman of PCRS Network, and Vice-Chairman of Association of Clinical Rresearch Professionals (ACRP)
Heidi Guthrie, Associate Director, CRO Services, ProSciento, Inc.
Claudia Shojai, Clinical Research Manager, DNA Electronics, Inc
Lisa Bjornestad, Director Site Alliance, the Americas at PAREXEL
Join us on December 4, 2018 at Biocom at 8am

January 28, 2019-Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice

Date
8am - 10am
Location
Biocom: McGraw Boardroom- 10996 Torreyana Rd. Suite 200, San Diego, CA 92121

Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice

Pharmatest Services and Taconic Biosciences welcome everyone to a seminar titled “Preclinical efficacy models for immuno-oncology studies in humanized mice”. Humanized mouse models include functional human immune system, which allows testing efficacy of immunotherapies on human cancer cells in immunocompetent mice. The seminar also discusses the importance of using preclinical metastasis models to confirm efficacy before entering clinical trials.

- 8.00 – 8.30: Registration and networking
- 8.30 – 8.45: Introduction, by Jussi Halleen, CEO, Pharmatest Services
- 8.45 – 9.15: Humanized Immune System Models: Novel Models for Novel Immunotherapies, by Paul Volden, Associate Director of External Collaboration and Innovation at Taconic Biosciences
- 9.15 – 9.45: Humanized mouse models of bone metastasis, by Tiina Kähkönen, Research Director at Pharmatest Services
- 9.45 – 10.00: Q&A

Speakers:
Paul Volden, Associate Director of External Collaboration and Innovation, Taconic Biosciences
Tiina Kähkönen, Research Director, Pharmatest Services